4DMedical, a company at the forefront of respiratory imaging innovation, has announced it has successfully raised $100.0 million in new investment capital from investors. This significant funding round marks a pivotal moment for the company as it continues to advance its disruptive medical technology.
The company is dedicated to transforming respiratory imaging through the application of truly disruptive technologies capable of revealing lung function and motion throughout every point of each lung. 4DMedical's unique XV Technology quantitatively reveals patterns of regional lung function in a four-dimensional and highly visual manner. This provides researchers, clinicians, and patients with insights into respiratory function that existing modalities often cannot, thereby informing diagnoses and empowering decision-makers. The company's expertise in measuring and reporting ventilation (V) is now extending into perfusion (Q), utilising existing and widely available X-ray and computed tomography [CT] imaging infrastructure, all with the goal that better information leads to better outcomes.
The $100.0 million secured in this funding round underscores strong investor confidence in 4DMedical's innovative approach and its potential to significantly impact medical diagnostics. This substantial capital injection will be strategically deployed to accelerate the company's product development roadmap, particularly in expanding its XV Technology into new applications and markets. Furthermore, the funds are earmarked for scaling operational capabilities, enhancing research and development efforts, and expanding its global commercial footprint. This investment is crucial for advancing 4DMedical's mission to provide superior diagnostic tools in respiratory health and solidify its position as a leader in the field.
With this significant financial backing, 4DMedical is well-positioned for substantial growth and continued innovation. The company plans to leverage this investment to further its mission of transforming respiratory diagnostics, broaden the application of its technology, and ultimately enhance diagnostic capabilities and patient care on a global scale.
